Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: A southwest oncology group study

Stephen K. Williaon, John J. Crowley, Robert B. Livingston, Timothy J. Panella, John Wendall Goodwin

Research output: Contribution to journal › Article › peer-review